Vazirani Asset Management LLC Invests $908,000 in Amedisys, Inc. (NASDAQ:AMED)

Vazirani Asset Management LLC acquired a new position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 10,000 shares of the health services provider's stock, valued at approximately $908,000. Amedisys accounts for about 2.8% of Vazirani Asset Management LLC's holdings, making the stock its 8th biggest position.

Several other hedge funds also recently modified their holdings of the stock. Vanguard Group Inc. increased its stake in Amedisys by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 3,216,120 shares of the health services provider's stock valued at $291,992,000 after purchasing an additional 10,817 shares in the last quarter. Norges Bank acquired a new stake in shares of Amedisys in the 4th quarter worth about $83,061,000. Alpine Associates Management Inc. lifted its position in Amedisys by 3.2% in the 4th quarter. Alpine Associates Management Inc. now owns 888,120 shares of the health services provider's stock valued at $80,632,000 after acquiring an additional 27,403 shares in the last quarter. Wealthfront Advisers LLC bought a new position in Amedisys in the 4th quarter valued at about $72,970,000. Finally, Alliancebernstein L.P. increased its holdings in Amedisys by 2.0% during the 4th quarter. Alliancebernstein L.P. now owns 677,787 shares of the health services provider's stock worth $61,536,000 after purchasing an additional 13,587 shares in the last quarter. Institutional investors own 94.36% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. Stephens reaffirmed an "equal weight" rating and set a $101.00 target price on shares of Amedisys in a research report on Tuesday, March 4th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $100.00 price objective on shares of Amedisys in a report on Wednesday, April 16th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $100.75.

Amedisys Stock Performance

Shares of AMED traded up $0.80 on Friday, reaching $96.00. 1,114,163 shares of the company's stock traded hands, compared to its average volume of 412,731. The stock's 50 day simple moving average is $92.58 and its two-hundred day simple moving average is $91.77. The stock has a market cap of $3.15 billion, a PE ratio of 38.10, a PEG ratio of 1.78 and a beta of 0.96. Amedisys, Inc. has a 52-week low of $82.15 and a 52-week high of $98.95. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED - Get Free Report) last released its earnings results on Wednesday, April 23rd. The health services provider reported $1.25 EPS for the quarter, topping analysts' consensus estimates of $1.13 by $0.12. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The company had revenue of $594.78 million for the quarter, compared to analysts' expectations of $597.43 million. During the same period in the previous year, the business posted $1.03 EPS. The business's revenue for the quarter was up 4.1% compared to the same quarter last year. On average, analysts forecast that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.